iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.
Raised
$33M
Investors
61
Min Invest
$250,000
Is this your company or fund? Claim this page free.
AltStreet Analysis
·Generated from EDGAR primary sources
iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. is a Delaware limited partnership filed by iCapital Advisors LLC on February 13, 2015. The fund raised $33.0M from 61 investors under Rule 506(b) and Section 3(c) exemptions, with a $250K minimum investment. This appears to be a pooled investment vehicle focused on alternative investments, specifically royalty opportunities.
This pooled investment fund operates under the common 506(b)/3(c) exemption structure typical of private alternative investment vehicles. The $250K minimum investment threshold positions it in the mass-affluent to high-net-worth segment, accessible to accredited investors but below the institutional-only minimums ($1M+) common in large private equity or hedge funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
AltStreet Coverage
Original reporting from AltStreet's daily EDGAR monitoring covering iCapital and its filings.
Two iCapital HedgePremier/Millennium Feeders' Combined Reported Amount Sold More Than Doubled, From $712 Million to $1.44 Billion
The two vehicles' combined reported amount sold more than doubled, from $712 million to $1.44 billion, between their Form D amendments of November 6, 2025 and November 4, 2026. HedgePremier/Millennium USA III LP reported $845.7 million sold to 2,452 investors and HedgePremier/Millennium International II Ltd. $595.9 million to 1,680. The combined figures are AltStreet's addition across two notices; investor counts are per notice.
Platform coverage · Nov 2026
Blue Owl Net Lease Trust Form D/A: Investors and Dollars Sold Both Rise 46% in a Year to $9.2 Billion
A Form D/A filed August 27 puts Blue Owl Real Estate Net Lease Trust at 44,524 investors and $9.2 billion sold since inception, both up about 46% from the amendment filed a year earlier, as its September closing added $178.6 million and the $2.45 billion Sila Realty Trust take-private closed on credit-facility borrowings.
Platform coverage · Sep 2026
What Is a Form D Amendment? KKR Infrastructure V's D/A Tops $17 Billion
A Form D amendment updates an existing exempt-offering notice rather than announcing a new raise, and a 2026 filing from a KKR infrastructure fund shows exactly how that distinction plays out in the numbers.
Platform coverage · Sep 2026
iCapital-PEG Evergreen PE Offshore Fund Reports $414M Raised, Up 113% in One Year
A Form D/A filed July 20, 2026 shows total offering proceeds for the iCapital-managed Cayman segregated portfolio company more than doubled versus the prior annual amendment, with investor headcount rising 37% to 224.
Platform coverage · Aug 2026
From 49 to 92 Investors in a Year: A 1972-Vintage Quant Shop Is Quietly Winning the Wealth Channel
The annual Form D amendment iCapital filed August 19 for its Campbell Absolute Return feeder is the kind of document nobody reads — except this one measured something: an 88% jump in investors and $12 million of new capital in twelve months, the largest single-year move AltStreet has recorded for the entity, and a direct reading on how wealth advisers are buying systematic absolute return.
Platform coverage · Aug 2026
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
0
none on file
Investor
- The dated record: 11 facts with source, effective date and capture date, viewable as AltStreet knew them on any past day
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
iCapital Advisors LLC
Executive Officer · New York, NY
Questions About iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.?
iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. is a Delaware limited partnership organized in 2014 that filed a Form D with the SEC on February 13, 2015 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of pooled investment fund interests. AltStreet links the issuer to iCapital.
Is iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. legit?
AltStreet does not rate legitimacy; it reports the public record. iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. filed a Form D with the SEC on February 13, 2015 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $33,000,000 sold to 61 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to iCapital, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. raised?
iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. reported $33,000,000 sold from 61 investors of a $33,000,000 total offering as of the Form D filed February 13, 2015.
Who can invest in iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.
What is the minimum investment in iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.?
The Form D lists $250,000 as the minimum investment accepted from any outside investor as of February 13, 2015. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.?
The Form D lists 1 related person: iCapital Advisors LLC, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. located?
The issuer's address on its SEC filings is 441 Lexington Avenue, 9th Floor, New York, NY 10017. Its phone number of record is 646-214-7458. It is organized under the laws of Delaware.
How long is the iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P.?
The Form D reports a revenue range of Not Applicable.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Platform verification: the separate analyst-reviewed program for platforms, with right of reply and a document library.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.